Cargando…

Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease

BACKGROUND: Fine motor performance may serve as an early warning sign for reduced cognitive function. Physical activity can help preserve cognitive function; however, the relationship between fine motor performance and physical activity is not well understood. Therefore, this study examined the rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinstein, Ali A., Ngo, Dung, de Avila, Leyla, Price, Jillian K., Golabi, Pegah, Austin, Patrick, Escheik, Carey, Gerber, Lynn H., Younossi, Zobair M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Gastroenterology & Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054279/ https://www.ncbi.nlm.nih.gov/pubmed/36974658 http://dx.doi.org/10.1080/07853890.2023.2193422

Ejemplares similares

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
por: Weinstein, Ali A, et al.
Publicado: (2022)

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
por: Golabi, Pegah, et al.
Publicado: (2020)

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19
por: Stepanova, Maria, et al.
Publicado: (2022)

Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease
por: Mehta, Rohini, et al.
Publicado: (2016)

Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease
por: Sayiner, Mehmet, et al.
Publicado: (2016)

Impact of healthcare reform on the payer mix among young adult emergency department utilizers across the United States (2005–2015)
por: Bush, Haley, et al.
Publicado: (2018)

Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
por: Younossi, Zobair M., et al.
Publicado: (2021)

Exercise as an intervention for patients with end-stage liver disease: Systematic review
por: Locklear, Cameron T., et al.
Publicado: (2018)

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches
por: Singh, Amandeep, et al.
Publicado: (2022)

Epidemiology of Helicobacter pylori in Australia: a scoping review
por: Congedi, Jillian, et al.
Publicado: (2022)

Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab
por: Haider, Mahnur, et al.
Publicado: (2020)

Nomogram for predicting gallbladder stone in patients with type 2 diabetes mellitus: a retrospective study in the Chinese population
por: Wu, Tiantian, et al.
Publicado: (2023)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Diet Satisfaction and Adequate Food Intake in Patients with Chronic Liver Diseases
por: Gerber, Suzannah, et al.
Publicado: (2022)

Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?
por: Huang, Hsien-Hao, et al.
Publicado: (2018)

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
por: Poynard, Thierry, et al.
Publicado: (2015)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study
por: Choi, Ja Sung, et al.
Publicado: (2019)

Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction
por: Choi, Jong Wook, et al.
Publicado: (2019)

Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study
por: Tang, Xiaoping, et al.
Publicado: (2022)

Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study
por: Hu, Xiao-na, et al.
Publicado: (2018)

Adiponectin–leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance
por: Lu, Chia-Wen, et al.
Publicado: (2023)

A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma
por: Nieto, Tom, et al.
Publicado: (2018)

Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study
por: Yang, Yarong, et al.
Publicado: (2021)

The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease
por: Zhao, Enfa, et al.
Publicado: (2023)

Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study
por: Coelho, Juliana Moraes, et al.
Publicado: (2020)

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study
por: Huang, Rui, et al.
Publicado: (2023)

Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China
por: Huanan, Chen, et al.
Publicado: (2020)

The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018
por: Liu, Jie, et al.
Publicado: (2022)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

Lower systemic inflammation is associated with gut firmicutes dominance and reduced liver injury in a novel ambulatory model of parenteral nutrition
por: Samaddar, Ashish, et al.
Publicado: (2022)

Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population
por: Li, YangFan, et al.
Publicado: (2019)

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial
por: Haigh, Laura, et al.
Publicado: (2021)

Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study
por: Feng, Limin, et al.
Publicado: (2021)

Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population
por: Hung, Wei-Chieh, et al.
Publicado: (2016)

Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study
por: Iwaki, Michihiro, et al.
Publicado: (2022)

Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study
por: Mettananda, Chamila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fk1csodcem25pj97228g2rgafh